The Australian Government’s Take-Home Naloxone Pilot has been extended to 30 June 2021.
In 2016–17 there were 5,112 emergency department presentations and 9,636 hospitalisations due to opioid poisoning, with three deaths per day attributed to opioid harm which is higher than the road toll.
The Take-Home Naloxone pilot program is for:
people who are at risk of an opioid overdose or adverse reaction, their carers, friends and family members
approved providers such as community pharmacists, dispensing doctors and hospital pharmacists
Naloxone is a drug that can temporarily reverse the effects of an opioid overdose or adverse reaction.
Over the next few weeks you’ll see us promoting the Pilot on our social media channels and asking for feedback regarding people’s experience with Naloxone.